# Boston Scientific Corporation (BSX) — Q3-2011 Earnings Results

**Report date:** 2011-10-20 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2011

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 4.4%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.15 | N/A | +78.57% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautiously optimistic outlook despite some market challenges. They emphasized the strength of their product portfolio.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They noted ongoing challenges in certain markets but expressed confidence in long-term growth.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a significant EPS beat, indicating stronger-than-expected profitability. However, the stock fell by 4.4%, likely due to investor concerns about market challenges and the lack of revenue details. The cautious tone from management may have also contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2011_